Welcome to LookChem.com Sign In|Join Free

CAS

  • or

406939-92-2

Post Buying Request

406939-92-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

406939-92-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 406939-92-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,6,9,3 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 406939-92:
(8*4)+(7*0)+(6*6)+(5*9)+(4*3)+(3*9)+(2*9)+(1*2)=172
172 % 10 = 2
So 406939-92-2 is a valid CAS Registry Number.

406939-92-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[4,8-bis(2,2,2-trifluoroacetyl)-1,4,8,11-tetrazacyclotetradec-1-yl]-2,2,2-trifluoroethanone

1.2 Other means of identification

Product number -
Other names 1-[4,8-bis-(2,2,2-trifluoroacetyl)-1,4,8,11-tetraazacyclotetradec-1-yl]-2,2,2-trifluoroethanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:406939-92-2 SDS

406939-92-2Relevant articles and documents

Dramatically enhanced carbon acidity of the nitrobenzyl fragment in a nickel(II) scorpionate complex

Boiocchi, Massimo,Fabbrizzi, Luigi,Foti, Francesco,Monzani, Enrico,Poggi, Antonio

, p. 3417 - 3420 (2005)

(Chemical Equation Presented) The -CH2- group of the 2-nitrobenzyl pendant arm of the scorpionate complex I deprotonates in basic aqueous solution (pKa = 10.6), due to the coordination of the nitronate group to the nickel(II) center.

Plerixafor crystal form D, plerixafor intermediate crystal form S and preparation methods and application thereof

-

Paragraph 0055-0056, (2021/05/29)

The invention relates to a plerixafor crystal form D, a plerixafor intermediate crystal form S and preparation methods and application thereof. By preparing the plerixafor crystal form D, a plerixafor raw material medicine which is easier to store is obtained, the plerixafor crystallization process is simplified, and the plerixafor crystal form D is suitable for large-scale production. By preparing the plerixafor key intermediate crystal form S, the purification process of the intermediate is simplified, and the purity of the prepared plerixafor raw material medicine is improved.

Development and Evaluation of an 18F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression

Brickute, Diana,Braga, Marta,Kaliszczak, Maciej A.,Barnes, Chris,Lau, Doreen,Carroll, Laurence,Stevens, Elizabeth,Trousil, Sebastian,Alam, Israt S.,Nguyen, Quang-Dé,Aboagye, Eric O.

, p. 2106 - 2117 (2019/05/15)

In humans, C-X-C chemokine receptor type 4 (CXCR4) is a protein that is encoded by the CXCR4 gene and binds the ligand CXCL12 (also known as SDF-1). The CXCR4-CXCL12 interaction in cancer elicits biological activities that result in tumor progression and

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 406939-92-2